10x Genomics, Inc. - 10-Q Filing
10x Genomics filed its Q1 2026 Form 10-Q with the SEC on April 30, 2026. The filing includes unaudited financial statements showing product and service revenue of $98 million for the quarter ended March 31, 2026, compared to $75 million in Q1 2025. Licensing and royalty revenue was $4 million versus $3 million year-over-year.
Tickers: $TXG